Business
CytoSorbents Highlights CytoSorb Use in Sepsis Patients During Sepsis Awareness Month and World Sepsis Day 2020
MONMOUTH JUNCTION, N.J., Sept. 11, 2020 /PRNewswire/ -- CytoSorbents Corporation (Nasdaq: CTSO), a critical care immunotherapy leader commercializing its
About this update from Cytosorbents Corporation
[{"type":"text","content":"MONMOUTH JUNCTION, N.J., Sept. 11, 2020 /PRNewswire/ -- CytoSorbents Corporation (Nasdaq: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights new activities and the use of CytoSorb in sepsis patients across the world during Sepsis Awareness Month (September) and World Sepsis Day on September 13, 2020.\n\n \n \n \n \n \n \n\n \nSepsis arises when the body's immune response to an infection injures its own tissues and organs. Sepsis is often associated with excessive inflammation driven by a cytokine storm. This in turn may lead to serious complications such as shock, failure of vital organs, and death – especially if not recognized early and treated promptly. CytoSorb reduces cytokine storm through blood purification, with the goal of reducing the severity and complications of sepsis. This new video, released to coincide with World Sepsis Day and based loosely on a real-world case, explains from a fresh perspective how CytoSorb is used in patients with cytokine storm, septic shock, and multiple organ failure. \nDr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents stated, \"This year, World Sepsis Day takes on a completely new meaning for all of us, as sepsis from COVID-19 viral infection has gripped headlines, crippled businesses, changed our lives, and played a major role in the hospitalization of millions and the deaths of nearly one million people globally. However, as serious as the COVID-19 pandemic is, it is dwarfed by sepsis from ordinary, every-day infections that afflict an estimated 49 million people a year, killing 11 million, and is responsible for 1 in every 5 deaths worldwide annually. As a leader in treating cytokine storm and deadly inflammation in septic patients for many years, we are proud to do our part in raising awareness of the sepsis scourge, and supporting organizations throughout the world working to do the same.\" \nCytoSorbents is one of the original and oldest sponsors of the Sepsis Alliance's SEPSIS HEROES Gala, hosted by the Sepsis Alliance, that honors select individuals or organizations that have made a significant contribution to sepsis awareness and education among both the general public and healthcare profes...